Welcome to CDC stacks | CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group - 7096 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Previous Button
Previous Button
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group
Record #: 147 of 794
Next Button
  • Published Date:
    December 21/28, 2004
  • Status:
    current
  • Source:
    Circulation. 2004; 110(25):e550-3.
Next Button
Filetype[HTML]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group
    Corporate Author:
    American Heart Association.. Centers for Disease Control and Prevention (U.S.).
    Published:
    December 21/28, 2004
    Source:
    Circulation. 2004; 110(25):e545-9.
    Status:
    current
    File Type:
    Filetype[HTML]
  2. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group
    Corporate Author:
    American Heart Association.. Centers for Disease Control and Prevention (U.S.).
    Published:
    December 21/28, 2004
    Source:
    Circulation. 2004; 110(25):e554-9.
    Description:
    This article summarizes epidemiological studies of inflammation markers, particularly C-reactive protein, and cardiovascular disease as of early 2002. Gaps in the research and the public health practice implications are also discussed. Although consi...
    Status:
    current
    File Type:
    Filetype[HTML]
  3. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
    Published:
    January 28, 2003
    Source:
    Circulation. 2003; 107(3):499-511.
    Status:
    current
    File Type:
    Filetype[HTML]
  4. Exposure to Polycyclic Aromatic Hydrocarbons and Serum Inflammatory Markers of Cardiovascular Disease
    Personal Author:
    Clark, John D.; Serdar, Berrin; Lee, David J.; Arheart, Kristopher; Wilkinson, James D.; Fleming, Lora E.;
    Published:
    May 22 2012
    Source:
    Environ Res. 2012; 117:132-137.
    Description:
    Polycyclic aromatic hydrocarbons (PAHs) are environmental and occupational carcinogens produced by the incomplete combustion of organic materials, such as coal and petroleum product combustion, tobacco smoking, and food cooking, that may be significa...
    File Type:
    Filetype[PDF - 50.81 KB]
  5. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute
    Personal Author:
    Luepker, Russell V.; Apple, Fred S.; Christenson, Robert H.; Crow, Richard S.; Fortmann, Stephen P.; Goff, David; Goldberg, Robert J.; Hand, Mary M.; Jaffe, Allan S.; Julian, Desmond G.; Levy, Daniel; Manolio, Teri; Mendis, Shanthi; Mensah, George; Pajak, Andrzej; Prineas, Ronald J.; Reddy, K. Srinath; Roger, Veronique L.; Rosamond, Wayne D.; Shahar, Eyal; Sharrett, A. Richey; Sorlie, Paul; Tunstall-Pedoe, Hugh;
    Corporate Author:
    American Heart Association. Council on Epidemiology and Prevention.. American Heart Association. Statistics Committee.. World Heart Federation Council. on Epidemiology and Prevention.. European Society of Cardiology. Working Group on Epidemiology and Prevention.. Centers for Disease Control and Prevention (U.S.). National Heart, Lung, and Blood Institute..
    Published:
    November 18, 2003
    Source:
    Circulation. 2003; 108(20):2543-9.
    Description:
    An epidemic of coronary heart disease (CHD) began during the 20th century in most industrialized countries, where CHD is a leading cause of mortality among adults.1 Developing countries show the beginnings of the same epidemic. Reliable information o...
    Status:
    current
    File Type:
    Filetype[HTML]